🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, controlled, open-label, multicenter study to evaluate...
Status
Unknown
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2020-05-20
Trial ID
NCT04385550
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of Anlotinib com...
Status
Unknown
Location
Beijing Hospital
Start Date
2020-03
Trial ID
NCT04291248
This study is a two arm, randomized, prospective, multicenter study on the ...
Status
Recruiting
Location
The First Affiliated Hospital of the Air Force Medical University
Start Date
2023-04-03
Trial ID
NCT06586242
Treatments Being Tested
This is a prospective, open-label single-arm, exploratory, two-stage design...
Status
Unknown
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2021-09
Trial ID
NCT05033587
Treatments Being Tested
This is a multi-center,open-label study to evaluate the efficacy and safety...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2018-11-22
Trial ID
NCT04172571
Treatments Being Tested
This study will explore the effectiveness and safety of the combination the...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-12
Trial ID
NCT05485350
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of AK105 (...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-01
Trial ID
NCT05137171
Treatments Being Tested
AK105 is a humanized monoclonal antibody that specially binds to PD-1. Anlo...
Status
Unknown
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2020-05-09
Trial ID
NCT04203719
This prospective observational study will evaluate the efficacy and safety ...
Status
Unknown
Location
The First Affiliated Hospital of Xinxiang Medical College
Start Date
2022-05-16
Trial ID
NCT05319886
Treatments Being Tested
This is a phase III , randomized, double-blinded, multicenter clinical stud...
Status
Terminated
Location
Chinese PLA General Hospital
Start Date
2018-11-27
Trial ID
NCT03866980
Treatments Being Tested